Keeping Safe and Effective Medications Accessible
J Med Toxicol
.
2023 Jul;19(3):244-245.
doi: 10.1007/s13181-023-00949-z.
Epub 2023 May 26.
Authors
Maryann Mazer-Amirshahi
1
2
,
Peggy Ye
3
4
,
Andrew Stolbach
5
Affiliations
1
Georgetown University School of Medicine, Washington, DC, USA.
[email protected]
.
2
Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC, 20010, USA.
[email protected]
.
3
Georgetown University School of Medicine, Washington, DC, USA.
4
Department of Obstetrics and Gynecology, MedStar Washington Hospital Center, Washington, DC, USA.
5
Department of Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA.
PMID:
37233913
PMCID:
PMC10293496
DOI:
10.1007/s13181-023-00949-z
No abstract available
Keywords:
Drug approval; Drug safety; Food and Drug Administration; Mifepristone.
Publication types
Editorial
MeSH terms
Drug Approval*
Humans
Mifepristone*
United States
United States Food and Drug Administration
Substances
Mifepristone